ophthalmology
Central Corneal Thickness Correction for Goldmann IOP
Central corneal thickness (CCT) affects Goldmann applanation readings, but published correction formulae disagree and none improves glaucoma risk prediction (OHTS). CCT is recorded and used as a risk factor alongside IOP.
Used in: Acute Red Eye
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Netarsudil 0.02% Eye Drops · Rho-kinase (ROCK) Inhibitor — Glaucoma
- Tafluprost 0.0015% Eye Drops · Prostaglandin Analogue — Glaucoma (Preservative-Free)
- Dorzolamide / Timolol Fixed Combination (Cosopt) · Fixed Combination Glaucoma Treatment — CAI + Beta-blocker
- Latanoprostene Bunod 0.024% Eye Drops · Nitric Oxide-donating Prostaglandin Analogue — Glaucoma
- Brimonidine / Timolol Fixed Combination · Fixed Combination Glaucoma Treatment — Alpha-2 Agonist + Beta-blocker
- Betaxolol 0.5% Eye Drops · Cardioselective Beta-1 Blocker — Glaucoma
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.